Income Taxes (Details 2) - USD ($)	6 Months Ended	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2023	Jun. 30, 2022
Income Taxes
Computed "expected" income tax benefit	$ (855,400)	$ (1,908,900)	$ 2,369,200
Research and development credits	(49,600)	(9,400)	(99,200)
Incentive Stock Option Expense	36,600	73,300	64,300
PPP Loan Foregivness	0	0	(91,100)
Valuation allowance	1,302,600	2,883,700	5,116,000
Aquila Biolabs GmbH operating loss	(245,700)	(1,150,800)	(717,100)
Differences between estimated financial income tax provision and actual filed tax return results	(187,800)	112,100	0
Other, net	(700)	0	491,100
Income tax expense /(benefit)	$ 0	$ 0	$ 2,394,800